Expert outlook: Addressing current trends and challenges in clinical research with mass spectrometry

contributed by Thermo Fisher Scientific | 06/22/2018

The healthcare industry looks toward new solutions to provide better outcomes at lower costs. With more treatment decisions now based on clinical lab results, labs play an important supporting role. Lab tests include screening, detection, and confirmation of various analytes for drugs-ofabuse testing and drug monitoring research. In drugs-of-abuse testing, labs continue to see a rise in novel psychoactive substances (NPS).

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.